Dr. Steven Nissen, chair of Cleveland Clinic’s cardiovascular medicine department, talks about why head-to-head clinical trials of competing drugs and devices would benefit patients.
“In medicine, we have many alternative therapies for patients,” he said. “What we need to know to take good care of our patients is which of these therapies is best.”
Nissen spoke at the Cleveland Clinic Medical Innovation Summit.
6 niche markets for telemedicine
With hepatitis C compound in phase 2, Scynexis raises $11.5M of $15M target
Nashville medical mart adds biggest tenant yet, a multi-vendor RFID technology showroom
Alogliptin’s European drug application triggers $10M milestone for FURX
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Merrill GooznerPharma, device firms kill conflict of interest rule, win accelerated approval
Dr. John D. HalamkaBYOD makes mobile security more complicated
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Amy SiegelTop 5 anxiety-provoking medtech acronyms
Stephen Schimpff MDIntegrative Medicine Part II — Health Care of the Future
John Mandrola, MDWeighing the risks of Pradaxa vs. the risk of stroke
Comments
Post a comment
Bravo! This is long overdue
Comment by Hans-Harald Lutzmann — October 5, 2011 @ 11:15 am
I agree with Dr. Nissen. As a previous chair of a large teaching hospital Pharmacy and Therapeutics Committee, which later became the Therapeutics Committee, we started down this path in 2004 and created a new healthcare economic model called Thereconomics, which I have two publications on and present during Comparative Effectiveness presentations and have presented as part of Health Care Reform discusions and to the AHRQ. What is best for a patient: Surgery, a drug, a device,? What about diagnostics: what is best clinical study-lab, radiology, etc? It goes beyond drug to drug head to hea studies.
Comment by Fred J. Pane, R.Ph, FASHP — October 11, 2011 @ 6:41 am
Post a Comment